Barrett & Company »

CNS Pharmaceuticals shares owned by Barrett & Company

Quarter-by-quarter ownership of CNS Pharmaceuticals (CNSP) shares owned by Barrett & Company from 13F filings

Historical chart of Barrett & Company investment in CNS Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including CNS Pharmaceuticals held by Barrett & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CNS Pharmaceuticals by Barrett & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $72 8 9.00

More positions owned by Barrett & Company

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Msci Usa Min Vol (USMV)
NVIDIA Corporation (NVDA)
Ishares Tr Morningstar Valu (ILCV)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Ishares Tr Future Exponenti (XT)
Vanguard Specialized Funds Div App Etf (VIG)
Vanguard Index Fds Growth Etf (VUG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
First Tr Exchange-traded SHS (FVD)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Amazon (AMZN)

View all positions for Barrett & Company

Top funds holding CNS Pharmaceuticals

DRW Holdings
UBS Group
Barrett & Company
MAI Wealth Advisors
Danske Bank A/s

View all funds holding CNS Pharmaceuticals